Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration
Michiko Horiguchi,Yuki Oiso,Hitomi Sakai,Tomoki Motomura,Chikamasa Yamashita-2015-07-07-Journal of Controlled Release
27
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
WortmanninPI3K/AKT/mTOR pathwayCOPDProtein kinase BMedicinePhosphoinositide 3-kinaseRegeneration (biology)Pharmacology
Chat
Click to start Chat